We serve Chemical Name:5-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-3,4-dihydropyrazole CAS:14295-72-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-3,4-dihydropyrazole
CAS.NO:14295-72-8
Synonyms:5-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-3,4-dihydropyrazole
Molecular Formula:C16H15ClN2O2S
Molecular Weight:334.82100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:527.2ºC at 760mmHg
Density:1.34g/cm3
Index of Refraction:1.641
PSA:58.12000
Exact Mass:334.05400
LogP:3.93930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-3,4-dihydropyrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-3,4-dihydropyrazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-3,4-dihydropyrazole Use and application,5-(4-chlorophenyl)-2-(4-methylsulfonylphenyl)-3,4-dihydropyrazole technical grade,usp/ep/jp grade.
Related News: He said it is “normal” for scientists and clinicians to discuss and debate data from experiments and clinical trials, but added those discussions have taken a turn “outside the boundaries of legitimate scientific deliberation.” 3-(2-Aminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride (1:1) manufacturers Over the past two to three years, VBP has become “quite a challenge,” AZ’s international and China market chief Leon Wang said on the call. In response, the company has resorted to multichannel marketing, turning to the retail pharmacy market to soften the blow of tender losses. ethyl 4-pyridin-3-ylpiperidine-4-carboxylate suppliers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. Kushenol B vendor & factory.
